Elevation Oncology, Inc.
ELEV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $32,223 | $18,300 | $22,104 | $139,700 |
| - Cash | $49,464 | $49,255 | $45,917 | $146,284 |
| + Debt | $31,134 | $30,137 | $29,435 | $0 |
| Enterprise Value | $13,893 | -$818 | $5,622 | -$6,584 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$24 | -$39 | -$27 | -$18 |
| % Margin | – | – | – | – |
| EBITDA | -$44,703 | -$41,467 | -$94,522 | -$32,028 |
| % Margin | – | – | – | – |
| Net Income | -$44,485 | -$45,704 | -$95,080 | -$32,039 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.78 | -1.34 | -4.09 | -1.38 |
| % Growth | 41.8% | 67.2% | -196.4% | – |
| Operating Cash Flow | -$36,364 | -$56,180 | -$85,483 | -$30,167 |
| Capital Expenditures | $0 | $0 | -$86 | $0 |
| Free Cash Flow | -$36,364 | -$56,180 | -$85,569 | -$30,167 |